Advertisement

Cancer Immunology, Immunotherapy

, Volume 65, Issue 2, pp 235–241 | Cite as

8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015—May 20–22, Vancouver, Canada

  • Jeanette E. Boudreau
  • Maartje C. A. Wouters
  • Connie M. Krawczyk
Meeting Report

From May 20–22, 2015, Canadian and international scientists held an intense meeting in beautiful Vancouver, British Columbia, focused on immunotherapy of cancer. This year’s 8th CCIC meeting brought novel innovations from both academia and industry, broadly extended our understanding of large data analysis, targeted cell and antibody therapeutics and identified new challenges for the successful deployment of cancer immunotherapeutics. The collection of world-class scientists and the highly social meeting structure afforded an excellent opportunity for networking and discussing data. Many of the 14 speakers presented their ongoing basic and clinical studies in the context of historical data from their own and pioneering laboratories. The meeting was an outstanding reminder of the progress in the field of cancer immunotherapy, speaking to past successes and failures, current ambitions and future potential. Alone and in combination with additional interventions, immunotherapeutics are...

Keywords

Immunotherapy Cancer microenvironment Checkpoint therapies Monoclonal antibody therapy Cancer genomics Adoptive T cell therapy 

Abbreviations

AdV

Adenovirus

BTK

Bruton’s tyrosine kinase

CAR-T

Chimeric antigen receptor T cell

CCIC

Canadian Cancer Immunotherapy Consortium

ccRCC

Clear cell renal cell carcinoma

CMV

Cytomegalovirus

CSK

c-Src kinase

DC

Dendritic cell

dPCR

Digital polymerase chain reaction

EBV

Epstein–Barr virus

INSERM

Institut National de la Santé et de la Recherche Médicale

JAK3

Janus kinase 3

JC

John Cunningham virus

LAMP

Lysosomal-associated membrane protein

LCK

Lymphocyte-specific protein tyrosine kinase

MDSC

Myeloid-derived suppressor cells

NGS

Next-generation sequencing

NK

Natural killer

NSCLC

Non-small cell lung carcinoma

POG

Personalized oncogenomics

TAM

Tumor-associated macrophages

TCR

T cell receptor

TIL

Tumor-infiltrating lymphocytes

TLS

Tertiary lymphoid structures

Treg

Regulatory T cell

VST

Virus-specific T cell

VZV

Varicella zoster virus

YES

Cellular homolog of the Yamaguchi sarcoma virus oncogene

Notes

Compliance with ethical standards

Conflict of interest

The authors declare no conflicts of interest. Connie Krawczyk participated in the organization of this CCIC meeting as coordinator of knowledge dissemination and outreach.

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Jeanette E. Boudreau
    • 1
  • Maartje C. A. Wouters
    • 2
  • Connie M. Krawczyk
    • 3
  1. 1.Sloan Kettering InstituteMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.University of Groningen, University Medical Center Groningen, Departments of Obstetrics and Gynecology and Medical MicrobiologyGroningenThe Netherlands
  3. 3.Departments of Microbiology and Immunology and Physiology, Goodman Cancer Research CenterMcGill UniversityMontrealCanada

Personalised recommendations